We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Smartwatch Algorithm Detects Cardiac Arrest

By HospiMedica International staff writers
Posted on 04 Mar 2025
Print article
Image: A consumer smartwatch with the AI algorithm could identify automated loss of pulse detection (Photo courtesy of Adobe Stock)
Image: A consumer smartwatch with the AI algorithm could identify automated loss of pulse detection (Photo courtesy of Adobe Stock)

Out-of-hospital cardiac arrest is a critical emergency that demands immediate recognition and response; in cases of sudden, unwitnessed cardiac arrest, survival chances are extremely low. One of the key indicators of cardiac arrest is the sudden loss of a pulse. The use of automated biosensors to detect unwitnessed cardiac arrest and prompt medical assistance could significantly improve survival rates, given the critical role of time in determining outcomes. However, for such systems to be effective, minimizing the false positive burden on emergency medical services is essential. Researchers have now developed an artificial intelligence (AI) system for a smartwatch that can detect signs of cardiac arrest and automatically alert emergency responders. This machine-learning algorithm, partially trained on data from patients whose hearts were intentionally stopped during medical procedures, is capable of recognizing the key indicators of cardiac arrest. While the researchers believe this system could potentially save lives, further testing is necessary to confirm its effectiveness.

The smartwatch algorithm, which leverages machine learning, was developed by Google Research (Mountain View, CA, USA), and is designed to meet performance standards suitable for large-scale use. The researchers first utilized photoplethysmography (PPG) to demonstrate that PPG measurements of peripheral pulselessness (induced by an arterial occlusion model) mirror the signal pattern of pulselessness seen in ventricular fibrillation (VF), a common arrhythmia associated with cardiac arrest. By analyzing the similarity between the PPG signals from VF and those from the occlusion model, they developed and validated a pulse loss detection algorithm using data collected from both the simulated model and real-world conditions.

Once the algorithm was developed, the researchers tested it in real-world scenarios. The results, published in Nature, showed that the system generated one unintentional emergency call per 21.67 user-years across two prospective studies. The algorithm’s sensitivity was 67.23% (with a 95% confidence interval of 64.32%–70.05%) when tested in a simulated arterial occlusion model of cardiac arrest. These findings indicate that this new technology offers a promising solution for wearable detection of sudden pulse loss while minimizing the societal impact of false alarms.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Endoscopic Surgical Medical Monitor
E2421
New
Ultrasound Needle Guide
Ultra-Pro 3

Print article

Channels

Surgical Techniques

view channel
Image: The magnetics microrobots removed blood clots from sheep iliac artery (Photo courtesy of University of Twente)

Screw-Shaped Magnetic Microrobots to Transform Treatment for Patients with Inoperable Blood Clots

Cardiovascular conditions such as thrombosis pose a significant global health issue, with blood clots being responsible for one in four deaths worldwide each year. A blood clot can obstruct a blood vessel,... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.